PDCD1 and neoplasm: In support of our findings, a similar observation of the improved anti-tumor effect has been documented with the combination of IDO-targeting Salmonella and PD-1/CTLA-4 inhibitors in the murine LLC1 tumor model in comparison to either Salmonella alone or PD-1/CTL1-4 mAb alone (103).